Judith Waltz Discusses Provider Relief Fund Settlements in OIG Investigations
04 October 2021
Report on Medicare Compliance
Foley & Lardner LLP Partner Judith Waltz was quoted in a Report on Medicare Compliance article, “More Providers Settle CMP Cases Over PRF; OIG: Attestations Had False Information,” about two health providers that have settled allegations of false statements made in order to get money from the HHS Provider Relief Fund (PRF). Both civil monetary penalty settlements stemmed from affirmative enforcement actions by the HHS Office of Inspector General (OIG), based on information that was available to OIG, not self-disclosures.
“OIG is aggressively pursuing entities that don’t comply with the PRF terms and conditions and perhaps the same will be true of reporting requirements,” said Waltz.
(Subscription required)
People
Related News
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."
19 September 2024
In the News
Patrick Daugherty on UChicago's Desk Reference for Crypto, Web3 – 'This is very much for lawyers'
Foley & Lardner LLP partner Patrick Daugherty commented on the University of Chicago Law School's recently released open-access legal desk reference on crypto and Web3 matters in the Law.com article, "UChicago Law Professors Release Desk Reference Breaking Down Crypto, Web 3 for Attorneys."
18 September 2024
In the News
Eli Mazour Talks Patents on IPWatchdog Unleashed Podcast
Foley & Lardner of counsel Eli Mazour appeared on the IPWatchdog Unleashed podcast episode, "Problems, Solutions and the Case for Patents," to discuss patents and innovation, the Federal Circuit, the value of patents to clients, and patent strategy.